Trials / Completed
CompletedNCT04503746
A Study to Evaluate the Efficacy and Safety of ALH-L1005 in Patients With Chronic Periodontitis
A Multi-center, Randomized, Double-Blind, Phase II Clinical Trial to Evaluate the Efficacy and Safety of 12-week Treatment of ALH-L1005 600 mg or 1200 mg in Patients With Chronic Periodontitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 117 (actual)
- Sponsor
- AngioLab, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 78 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to evaluate efficacy and safety of ALH-L1005 in patients with chronic periodontitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALH-L1005 600mg/day | ALH-L1005 300mg 2 tablet and placebo 2 tablet |
| DRUG | ALH-L1005 1,200mg/day | ALH-L1005 300mg 4 tablet |
| DRUG | Placebo | Placebo 4 tablet |
Timeline
- Start date
- 2020-07-16
- Primary completion
- 2021-12-13
- Completion
- 2021-12-13
- First posted
- 2020-08-07
- Last updated
- 2022-08-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04503746. Inclusion in this directory is not an endorsement.